Clinical trial
CHORD1 - CHOlesterol Lowering and Residual Risk in Diabetes, Type 1
NCT05641753 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CHORD1 - CHOlesterol Lowering and Residual Risk in Diabetes, Type 1
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 6, 2022
- Completion date
- July 31, 2027
- Enrollment
- 125 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes